Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis: A case report and literature review

BACKGROUND: Primary splenic angiosarcoma (PSA) is an extremely rare and aggressive mesenchymal malignancy with high metastatic potential and a poor prognosis. There are no established treatment guidelines for PSA, even for adjuvant therapy. This rare case may provide a reliable therapeutic regime fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Dan, Li, Tai-Ping, Xiong, Jian-Hui, Wang, Shu-Bo, Chen, Yao-Xu, Li, Jian-Feng, Xiao, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968800/
https://www.ncbi.nlm.nih.gov/pubmed/35434106
http://dx.doi.org/10.12998/wjcc.v10.i9.2818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968800/
https://www.ncbi.nlm.nih.gov/pubmed/35434106
http://dx.doi.org/10.12998/wjcc.v10.i9.2818

Ejemplares similares